Literature DB >> 18466866

Gallbladder cancer.

Stavros Gourgiotis1, Hemant M Kocher, Leonardo Solaini, Arvin Yarollahi, Evangelos Tsiambas, Nikolaos S Salemis.   

Abstract

BACKGROUND: Gallbladder cancer (GC) is a relatively rare but highly lethal neoplasm. We review the epidemiology, etiology, pathology, symptoms, diagnosis, staging, treatment, and prognosis of GC.
METHOD: A Pubmed database search between 1971 and February 2007 was performed. All abstracts were reviewed and articles with GC obtained; further references were extracted by hand-searching the bibliography. The database search was done in the English language.
RESULTS: The accurate etiology of GC remains unclear, while the symptoms associated with primary GC are not specific. Treatment with radical cholecystectomy is curative but possible in only 10% to 30% of patients. For patients whose cancer is an incidental finding on pathologic review, re-resection is indicated, where feasible, for all disease except T1a. Patients with advanced disease should receive palliative treatment. Laparoscopic cholecystectomy is contraindicated in the presence of GC.
CONCLUSION: Prognosis generally is extremely poor. Improvements in the outcome of surgical resection have caused this approach to be re-evaluated, while the role of chemotherapy and radiotherapy remains controversial.

Entities:  

Mesh:

Year:  2008        PMID: 18466866     DOI: 10.1016/j.amjsurg.2007.11.011

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  58 in total

Review 1.  Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature.

Authors:  Paul H Chung; Ramaprasad Srinivasan; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  Urol Oncol       Date:  2011-02-01       Impact factor: 3.498

2.  Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer.

Authors:  Tamotsu Takeuchi; Yoshihiro Adachi; Tomoko Nagayama; Mutsuo Furihata
Journal:  Int J Exp Pathol       Date:  2010-10-05       Impact factor: 1.925

3.  Metachronous pancreatic head ductal carcinoma three years after resection of gallbladder cancer.

Authors:  Dingwei Chen; Jiafei Yan; Yiping Mou
Journal:  Int J Clin Exp Med       Date:  2013-09-25

4.  A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer.

Authors:  Tsuyoshi Hayashi; Hirotoshi Ishiwatari; Makoto Yoshida; Tsutomu Sato; Koji Miyanishi; Yasushi Sato; Masayoshi Kobune; Rishu Takimoto; Tomoko Sonoda; Junji Kato
Journal:  Int J Clin Oncol       Date:  2011-09-21       Impact factor: 3.402

5.  NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells.

Authors:  Zhujun Tan; Maolan Li; Wenguang Wu; Lin Zhang; Qichen Ding; Xiangsong Wu; Jiasheng Mu; Yingbin Liu
Journal:  Mol Cell Biochem       Date:  2012-06-24       Impact factor: 3.396

Review 6.  Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread.

Authors:  Amit Nandan Dhar Dwivedi; Shivi Jain; Ruhi Dixit
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

7.  Audit of management of gallbladder cancer in a Nigerian tertiary health facility.

Authors:  O I Alatise; O O Lawal; A O Adisa; O A Arowolo; O O Ayoola; E A Agbakwuru; A R K Adesunkanmi; G O Omoniyi-Esan; O O Olaofe
Journal:  J Gastrointest Cancer       Date:  2012-09

8.  Surgical treatment of incidental gallbladder cancer discovered during or following laparoscopic cholecystectomy.

Authors:  Yuan-Hu Tian; Xu Ji; Bo Liu; Guang-Yun Yang; Xiang-Fei Meng; Hong-Tian Xia; Jing Wang; Zhi-Qiang Huang; Jia-Hong Dong
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

9.  Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).

Authors:  Zeeshan Butt; Neehar D Parikh; Jennifer L Beaumont; Sarah K Rosenbloom; Karen L Syrjala; Amy P Abernethy; Al B Benson; David Cella
Journal:  Cancer       Date:  2012-05-17       Impact factor: 6.860

Review 10.  New Horizons for Precision Medicine in Biliary Tract Cancers.

Authors:  Juan W Valle; Angela Lamarca; Lipika Goyal; Jorge Barriuso; Andrew X Zhu
Journal:  Cancer Discov       Date:  2017-08-17       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.